Search

Your search keyword '"De Smedt, Eva"' showing total 50 results

Search Constraints

Start Over You searched for: Author "De Smedt, Eva" Remove constraint Author: "De Smedt, Eva"
50 results on '"De Smedt, Eva"'

Search Results

8. Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype

9. Supplemental Table S3 from Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

10. Supplemental Figures S1-S7 from Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

11. Supplementary Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype

12. Data from Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

13. Supplemental materials and methods, supplemental references and supplemental figure legends from Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

14. Supplemental Tables S1, S4 and S5 from Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

19. Additional file 2 of Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma

20. The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype

21. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

23. The anaphase-promoting-complex/cyclosome: a new promising target in mantle cell lymphoma and diffuse large B cell lymphoma

24. Histone Methyltransferases G9a and GLP; Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Treatment

26. Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression

27. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

28. SET8 Is a Potential Therapeutic Target in MM

29. Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research

30. In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma

31. Pre-mediation and the achievement of media professionalism in the production of political broadcast talk

32. Structural and interactional orders of institutional talk: A framework for the study of power and identity as members’ accomplishments within conversation analysis

33. In vivo gene expression profling in the murine 5T33MM model identifies epigenetic-regulated genes predictive for prognosis and drug sensitivity

35. Power-in-interaction: A study of the dynamic play of power in political TV debates

36. Political television formats as strategic resources in achieving journalists’ roles

37. On the interactional achievement of journalistic neutrality in political television debates

38. Journalists and politicians in interaction: A study of the interactional dynamics in political interviews and television debates

39. 'Doing power' in institutional interaction: a study of the dynamic play of power in political television debates

40. Power-in-interaction: A study of the dynamic play of power in political television debates

41. New formats, new styles? A comparative study of the Flemish and Walloon public television coverage of the 2009 European and regional election campaign

42. Journalists and politicians in interaction. A study of the interactional power dynamics in political interviews and television debates

44. In vivotreatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma

47. The in vivoTranscriptional Response Towards Epigenetic Modulating Agents in Multiple Myeloma

48. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.

49. In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.

50. The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.

Catalog

Books, media, physical & digital resources